Reyes, A., Sun, L., Ha, R., Desperito, E., Brown, M., Francescone, M. A., Ugras, S., Wiechmann, L., Rao, R., & Taback, B. (2024). A Comprehensive Assessment of Radial Scars on Core Needle Biopsy in Patients with or without Breast Cancer: Upgrade Rate and Implications on Management. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.01.020

Zettler, C. M., De Silva, D. L., Blinder, V. S., Robson, M. E., & Elkin, E. B. (2024). Cost-Effectiveness of Adjuvant Olaparib for Patients With Breast Cancer and Germline BRCA1/2 Mutations. JAMA Network Open, 7(1), e2350067. https://doi.org/10.1001/jamanetworkopen.2023.50067

Zeng, C., Matias‐Gomez, L., Kelly, M., Hershman, D. L., Rosenberg, S., & Pinheiro, L. C. (2024). Psychosocial support among adults living with metastatic breast cancer: Perspectives from providers across four New York‐Presbyterian hospitals. Psycho-Oncology, 33(1). Portico. https://doi.org/10.1002/pon.6296

Li, W., Partridge, S. C., Newitt, D. C., Steingrimsson, J., Marques, H. S., Bolan, P. J., Hirano, M., Bearce, B. A., Kalpathy-Cramer, J., Boss, M. A., Teng, X., Zhang, J., Cai, J., Kontos, D., Cohen, E. A., Mankowski, W. C., Liu, M., Ha, R., Pellicer-Valero, O. J., … Hylton, N. M. (2024). Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 Challenge. Radiology: Imaging Cancer, 6(1). https://doi.org/10.1148/rycan.230033

A Brief Screening Tool for Assessment of Financial Toxicity. (2024). Oncology Nursing Forum. https://doi.org/10.1188/24.onf.17-23

Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Thompson, A. M., Rea, D. W., Stos, P. M., Shepherd, L. E., Stambolic, V., & Parulekar, W. R. (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology, 41(35), 5356–5362. https://doi.org/10.1200/jco.23.00296

Accordino, M. K., Lee, S., Leu, C. S., Levin, B., Trivedi, M. S., Crew, K. D., Kalinsky, K., Raghunathan, R., Faheem, K., Harden, E., Taboada, A., de Oliveira, B. D., Larson, E., Franks, L., Honan, E., Law, C., & Hershman, D. L. (2023). Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer. Breast Cancer Research and Treatment, 204(1), 49–59. https://doi.org/10.1007/s10549-023-07172-y

O’Neil, D. S., Martei, Y. M., Crew, K. D., Castillo, B. S., Costa, P., Lim, T., Michel, A., Rubin, E., Goel, N., Hurley, J., Lopes, G., & Antoni, M. H. (2023). Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV. JAMA Network Open, 6(12), e2346223. https://doi.org/10.1001/jamanetworkopen.2023.46223

Lawal, K. O., Nilan, L., Amenta, J., McGuinness, J. E., Kukafka, R., & Crew, K. D. (2023). Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions. Cancer Prevention Research, 16(12), 661–667. https://doi.org/10.1158/1940-6207.capr-23-0181

Levi, H., Carmi, S., Rosset, S., Yerushalmi, R., Zick, A., Yablonski-Peretz, T., Wang, Q., Bolla, M. K., Dennis, J., Michailidou, K., Lush, M., Ahearn, T., Andrulis, I. L., Anton-Culver, H., Antoniou, A. C., Arndt, V., Augustinsson, A., Auvinen, P., … Beane Freeman, L. (2023). Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics, 60(12), 1186–1197. https://doi.org/10.1136/jmg-2023-109185

Ayeni, O. A., Joffe, M., Mapanga, W., Chen, W. C., O’Neil, D. S., Phakathi, B., Nietz, S., Buccimazza, I., Čačala, S., Stopforth, L. W., Jacobson, J. S., Crew, K. D., Neugut, A. I., Ramiah, D., Ruff, P., Cubasch, H., Chirwa, T., McCormack, V., Micklesfield, L. K., & Norris, S. A. (2023). Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study. Breast Cancer Research, 25(1). https://doi.org/10.1186/s13058-023-01603-w

Shachar, S. S., Korzets, Y., Shepshelovich, D., Zlothover, N., Amir, E., Tibau, A., & Goldvaser, H. (2024). Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review. Cancer Treatment Reviews, 122, 102666. https://doi.org/10.1016/j.ctrv.2023.102666

Sanft, T., Harrigan, M., McGowan, C., Cartmel, B., Zupa, M., Li, F.-Y., Ferrucci, L. M., Puklin, L., Cao, A., Nguyen, T. H., Neuhouser, M. L., Hershman, D. L., Basen-Engquist, K., Jones, B. A., Knobf, T., Chagpar, A. B., Silber, A., Tanasijevic, A., Ligibel, J. A., & Irwin, M. L. (2023). Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal of Clinical Oncology, 41(34), 5285–5295. https://doi.org/10.1200/jco.23.00871

McCarthy, A. M., Fernandez Perez, C., Beidas, R. S., Bekelman, J. E., Blumenthal, D., Mack, E., Bauer, A.-M., Ehsan, S., Conant, E. F., Wheeler, B. C., Guerra, C. E., Nunes, L. W., Gabriel, P., Doucette, A., Wileyto, E. P., Buttenheim, A. M., Asch, D. A., Rendle, K. A., Shelton, R. C., … Schnoll, R. (2023). Protocol for a pragmatic stepped wedge cluster randomized clinical trial testing behavioral economic implementation strategies to increase supplemental breast MRI screening among patients with extremely dense breasts. Implementation Science, 18(1). https://doi.org/10.1186/s13012-023-01323-x

Kast, K., John, E. M., Hopper, J. L., Andrieu, N., Noguès, C., Mouret-Fourme, E., Lasset, C., Fricker, J.-P., Berthet, P., Mari, V., Salle, L., Schmidt, M. K., Ausems, M. G. E. M., Garcia, E. B. G., van de Beek, I., Wevers, M. R., Evans, D. G., Tischkowitz, M., … Lalloo, F. (2023). Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium. Breast Cancer Research, 25(1). https://doi.org/10.1186/s13058-023-01673-w

Daniel, O., Ashrafi, A., Muthoni, M. A., Njoki, N., Eric, H., Marilynn, O., Faith, A. B., Beth, W. G., Nyakio, M., Odero-Marah, V., Ragin, C., & Llanos, A. A. M. (2023). Delayed breast cancer presentation, diagnosis, and treatment in Kenya. Breast Cancer Research and Treatment, 202(3), 515–527. https://doi.org/10.1007/s10549-023-07067-y

Mueller, S. H., Lai, A. G., Valkovskaya, M., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Lush, M., Abu-Ful, Z., Ahearn, T. U., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Arndt, V., Aronson, K. J., Augustinsson, A., Baert, T., Freeman, L. E. B., … Beckmann, M. W. (2023). Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Medicine, 15(1). https://doi.org/10.1186/s13073-022-01152-5

Clapp, A., Murphy, A. I., Ascherman, J. A., & Rohde, C. H. (2024). Contralateral prophylactic mastectomy: Weighing the risks of delayed chemotherapy, radiotherapy, and hormonal therapy. Journal of Plastic, Reconstructive & Aesthetic Surgery, 89, 7–13. https://doi.org/10.1016/j.bjps.2023.11.040

Kim, D. K., Corpuz, G. S., Ta, C. N., Weng, C., & Rohde, C. H. (2024). Applying unsupervised machine learning approaches to characterize autologous breast reconstruction patient subgroups: an NSQIP analysis of 14,274 patients. Journal of Plastic, Reconstructive & Aesthetic Surgery, 88, 330–339. https://doi.org/10.1016/j.bjps.2023.11.016

Yeh, C., Zhou, M., Bapodra, N., Hershman, D., Espinal, E., Moran, M., Rivero, M., Fojo, A. T., & Bates, S. E. (2023). Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials. Breast Cancer Research and Treatment, 204(1), 39–47. https://doi.org/10.1007/s10549-023-07131-7

Kantor, E. D., O’Connell, K., Ergas, I. J., Valice, E., Roh, J. M., Bhimani, J., Heon, N., Griggs, J. J., Lee, J., Bowles, E. J., Rivera, D. R., Kolevska, T., Bandera, E. V., & Kushi, L. H. (2023). Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system. Breast Cancer Research and Treatment, 203(3), 565–574. https://doi.org/10.1007/s10549-023-07126-4

Derakhshan, F., Da Cruz Paula, A., Selenica, P., da Silva, E. M., Grabenstetter, A., Jalali, S., Gazzo, A. M., Dopeso, H., Marra, A., Brown, D. N., Ross, D. S., Mandelker, D., Razavi, P., Chandarlapaty, S., Wen, H. Y., Brogi, E., Zhang, H., Weigelt, B., Pareja, F., & Reis-Filho, J. S. (2024). Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization. Modern Pathology, 37(2), 100375. https://doi.org/10.1016/j.modpat.2023.100375

Varkaris, A., Pazolli, E., Gunaydin, H., Wang, Q., Pierce, L., Boezio, A. A., Bulku, A., DiPietro, L., Fridrich, C., Frost, A., Giordanetto, F., Hamilton, E. P., Harris, K., Holliday, M., Hunter, T. L., Iskandar, A., Ji, Y., Larivée, A., LaRochelle, J. R., … Kipp, D. R. (2023). Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discovery, 14(2), 240–257. https://doi.org/10.1158/2159-8290.cd-23-0944

Tehranifar, P., & Bertrand, K. A. (2023). Enhancing Mammography and Empowering Solutions for Breast Cancer Disparities. Cancer Epidemiology, Biomarkers & Prevention, 32(11), 1479–1481. https://doi.org/10.1158/1055-9965.epi-23-0926

Kim, S., Armand, J., Safonov, A., Zhang, M., Soni, R. K., Schwartz, G., McGuinness, J. E., Hibshoosh, H., Razavi, P., Kim, M., Chandarlapaty, S., & Yang, H. W. (2023). Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer. Cell Reports, 42(11), 113198. https://doi.org/10.1016/j.celrep.2023.113198

Vincent, R. L., Gurbatri, C. R., Li, F., Vardoshvili, A., Coker, C., Im, J., Ballister, E. R., Rouanne, M., Savage, T., de los Santos-Alexis, K., Redenti, A., Brockmann, L., Komaranchath, M., Arpaia, N., & Danino, T. (2023). Probiotic-guided CAR-T cells for solid tumor targeting. Science, 382(6667), 211–218. https://doi.org/10.1126/science.add7034

O’Neil, D. S., Ayeni, O. A., Farrow, H. A., Chen, W. C., Demetriou, G., Buccimazza, I., Čačala, S., Stopforth, L. W., Joffe, M., Antoni, M. H., Lopes, G., Pumpalova, Y. S., Mapanga, W., Jacobson, J. S., Crew, K. D., Neugut, A. I., Ruff, P., & Cubasch, H. (2023). The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer. The Oncologist, 28(10), e921–e929. https://doi.org/10.1093/oncolo/oyad056

Kehm, R. D., Lilge, L., Walter, E. J., White, M., Herbstman, J. B., Perera, F. P., Miller, R. L., Terry, M. B., & Tehranifar, P. (2023). Socioeconomic Status at Birth and Breast Tissue Composition in Adolescence and Adulthood. Cancer Epidemiology, Biomarkers & Prevention, 32(10), 1294–1301. https://doi.org/10.1158/1055-9965.epi-23-0444

Ferris, J. S., Morgan, D. A., Tseng, A. S., Terry, M. B., Ottman, R., Hur, C., Wright, J. D., & Genkinger, J. M. (2023). Risk factors for developing both primary breast and primary ovarian cancer: A systematic review. Critical Reviews in Oncology/Hematology, 190, 104081. https://doi.org/10.1016/j.critrevonc.2023.104081

Boughey, J. C., Yu, H., Dugan, C. L., Piltin, M. A., Postlewait, L., Son, J. D., Edmiston, K. K., Godellas, C. V., Lee, M. C., Carr, M. J., Tonneson, J. E., Crown, A., Lancaster, R. B., Woriax, H. E., Ewing, C. A., Chau, H. S., Patterson, A. K., Wong, J. M., Alvarado, M. D., … Mukhtar, R. A. (2023). Changes in Surgical Management of the Axilla Over 11 Years – Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. Annals of Surgical Oncology, 30(11), 6401–6410. https://doi.org/10.1245/s10434-023-13759-y

Marziliano, A., Miller, S. M., Fleisher, L. G., Ropka, M. E., Stanton, A. L., Wen, K.-Y., Cornelius, T., Lapitan, E., & Diefenbach, M. A. (2023). Examining the impact of a multimedia intervention on decisional conflict and psychological distress among early-stage breast cancer patients: results from a nationwide RCT. Translational Behavioral Medicine, 13(10), 727–735. https://doi.org/10.1093/tbm/ibad037

Singh, J., Sah, B., Shen, Y., & Liu, L. (2023). Histone methyltransferase inhibitor UNC0642 promotes breast cancer cell death by upregulating TXNIP-dependent oxidative stress. Chemico-Biological Interactions, 385, 110720. https://doi.org/10.1016/j.cbi.2023.110720

Doshi, S. D., DeStephano, D., Accordino, M. K., Elkin, E., Raghunathan, R. R., Wright, J. D., & Hershman, D. L. (2023). Disparities with influenza vaccine use in long-term survivors of metastatic breast cancer. Breast Cancer Research and Treatment, 203(1), 111–119. https://doi.org/10.1007/s10549-023-07109-5

Yoo, B., Kim, A., Moon, H. S., So, M.-K., Jeong, T.-D., Lee, K. E., Moon, B.-I., & Huh, J. (2023). Evaluation of Group Genetic Counseling Sessions via a Metaverse-based Application. Annals of Laboratory Medicine, 44(1), 82–91. https://doi.org/10.3343/alm.2024.44.1.82

Terry, M. B., & Colditz, G. A. (2023). Epidemiology and Risk Factors for Breast Cancer: 21st Century Advances, Gaps to Address through Interdisciplinary Science. Cold Spring Harbor Perspectives in Medicine, 13(9), a041317. https://doi.org/10.1101/cshperspect.a041317

Tarchi, S. M., Pernia Marin, M., Hossain, Md. M., & Salvatore, M. (2023). Breast stiffness, a risk factor for cancer and the role of radiology for diagnosis. Journal of Translational Medicine, 21(1). https://doi.org/10.1186/s12967-023-04457-0

Kalinsky, K., Accordino, M. K., Chiuzan, C., Mundi, P. S., Sakach, E., Sathe, C., Ahn, H., Trivedi, M. S., Novik, Y., Tiersten, A., Raptis, G., Baer, L. N., Oh, S. Y., Zelnak, A. B., Wisinski, K. B., Andreopoulou, E., Gradishar, W. J., Stringer-Reasor, E., Reid, S. A., … Hershman, D. L. (2023). Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial. Journal of Clinical Oncology, 41(24), 4004–4013. https://doi.org/10.1200/jco.22.02392

Lichtiger, L., Jezioro, J., Rivera, J., McDonald, J. D., Terry, M. B., Sahay, D., & Miller, R. L. (2023). Prenatal airborne polycyclic aromatic hydrocarbon exposure, altered regulation of peroxisome proliferator-activated receptor gamma (Ppar)γ, and links with mammary cancer. Environmental Research, 231, 116213. https://doi.org/10.1016/j.envres.2023.116213

Koch, P. A., Paul, R., Contento, I. R., Gray, H. L., Marín-Chollom, A. M., Santiago-Torres, M., Shen, H., Jones, S. M. W., Hershman, D. L., & Greenlee, H. (2023). Mi Vida Saludable: Content Validity and Reliability of The Preferences and Self-Efficacy of Diet and Physical Activity Behaviors Questionnaire for Latina Women (PSEDPALW) for Cancer Survivors. Nutrients, 15(16), 3563. https://doi.org/10.3390/nu15163563

Phakathi, B., Dix-Peek, T., Van Den Berg, E., Dickens, C., Nietz, S., Cubasch, H., Joffe, M., Neugut, A. I., Jacobson, J. S., Ruff, P., & Duarte, R. (2023). PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study. Breast Cancer Research and Treatment, 200(3), 337–346. https://doi.org/10.1007/s10549-023-06969-1

Morra, A., Schreurs, M. A. C., Andrulis, I. L., Anton‐Culver, H., Augustinsson, A., Beckmann, M. W., Behrens, S., Bojesen, S. E., Bolla, M. K., Brauch, H., Broeks, A., Buys, S. S., Camp, N. J., Castelao, J. E., Cessna, M. H., Chang‐Claude, J., Chung, W. K., Colonna, S. V., … Hooning, M. J. (2023). Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival. Cancer Medicine, 12(15), 16142–16162. Portico. https://doi.org/10.1002/cam4.6272

Trepanier, C., Huang, A., Liu, M., & Ha, R. (2023). Emerging uses of artificial intelligence in breast and axillary ultrasound. Clinical Imaging, 100, 64–68. https://doi.org/10.1016/j.clinimag.2023.05.007

Ding, Y. C., Song, H., Adamson, A. W., Schmolze, D., Hu, D., Huntsman, S., Steele, L., Patrick, C. S., Tao, S., Hernandez, N., Adams, C. D., Fejerman, L., Gardner, K., Nápoles, A. M., Pérez-Stable, E. J., Weitzel, J. N., Bengtsson, H., Huang, F. W., Neuhausen, S. L., & Ziv, E. (2023). Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics. Cancer Research, 83(15), 2600–2613. https://doi.org/10.1158/0008-5472.can-22-2510

Rillamas-Sun, E., Kwan, M. L., Iribarren, C., Cheng, R., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Huang, Y., Shen, H., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2023). Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Research and Treatment, 201(1), 117–126. https://doi.org/10.1007/s10549-023-06997-x

Xu, C., Lu, P., Pfob, A., Pusic, A. L., Hamill, J. B., & Sidey-Gibbons, C. (2023). Physical well-being recovery trajectories by reconstruction modality in women undergoing mastectomy and breast reconstruction: Significant predictors and health-related quality of life outcomes. PLOS ONE, 18(7), e0289182. https://doi.org/10.1371/journal.pone.0289182

Michel, A., Ro, V., McGuinness, J. E., Mutasa, S., Terry, M. B., Tehranifar, P., May, B., Ha, R., & Crew, K. D. (2023). Breast cancer risk prediction combining a convolutional neural network-based mammographic evaluation with clinical factors. Breast Cancer Research and Treatment, 200(2), 237–245. https://doi.org/10.1007/s10549-023-06966-4

Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2023). Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 200(1), 85–92. https://doi.org/10.1007/s10549-023-06957-5

Odai-Afotey, A., Lederman, R. I., Ko, N. Y., Gagnon, H., Fikre, T., Gundersen, D. A., Revette, A. C., Hershman, D. L., Crew, K. D., Keating, N. L., & Freedman, R. A. (2023). Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Research and Treatment, 200(1), 127–137. https://doi.org/10.1007/s10549-023-06960-w

Acheampong, T., Rodríguez, C. B., O’Neill, S. C., Agovino, M., Argov, E. J. L., & Tehranifar, P. (2023). Scientific uncertainty and perceived mammography benefits in women screened for breast cancer. Cancer Causes & Control, 34(7), 611–619. https://doi.org/10.1007/s10552-023-01697-9

Hershman, D. L., Chen, B. E., Sathe, C., Parulekar, W. R., Lemieux, J., Ligibel, J. A., Gelmon, K. A., Whelan, T. J., & Goodwin, P. J. (2023). Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32). Breast Cancer Research and Treatment, 200(1), 93–102. https://doi.org/10.1007/s10549-023-06922-2